Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Dujmovic, I. (6701590899)"

Filter results by typing the first few letters
Now showing 1 - 13 of 13
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Are Leber's mitochondial DNA mutations associated with aquaporin-4 autoimmunity?
    (2016)
    Dujmovic, I. (6701590899)
    ;
    Jancic, J. (35423853400)
    ;
    Dobricic, V. (22952783800)
    ;
    Jankovic, M. (54881096000)
    ;
    Novakovic, I. (6603235567)
    ;
    Comabella, M. (6701491362)
    ;
    Drulovic, J. (55886929900)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Are Leber's mitochondial DNA mutations associated with aquaporin-4 autoimmunity?
    (2016)
    Dujmovic, I. (6701590899)
    ;
    Jancic, J. (35423853400)
    ;
    Dobricic, V. (22952783800)
    ;
    Jankovic, M. (54881096000)
    ;
    Novakovic, I. (6603235567)
    ;
    Comabella, M. (6701491362)
    ;
    Drulovic, J. (55886929900)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study
    (2015)
    Kuhle, J. (8937520800)
    ;
    Disanto, G. (26631703200)
    ;
    Dobson, R. (36093903900)
    ;
    Adiutori, R. (56156549300)
    ;
    Bianchi, L. (57191438781)
    ;
    Topping, J. (12445497400)
    ;
    Bestwick, J.P. (14027999700)
    ;
    Meier, U.-C. (20734943500)
    ;
    Marta, M. (8578393000)
    ;
    Dalla Costa, G. (6506426520)
    ;
    Runia, T. (55315357700)
    ;
    Evdoshenko, E. (51763507000)
    ;
    Lazareva, N. (56720982800)
    ;
    Thouvenot, E. (35325407800)
    ;
    Iaffaldano, P. (25226936800)
    ;
    Direnzo, V. (25226632600)
    ;
    Khademi, M. (59554754700)
    ;
    Piehl, F. (7004836264)
    ;
    Comabella, M. (6701491362)
    ;
    Sombekke, M. (26024481200)
    ;
    Killestein, J. (7004423164)
    ;
    Hegen, H. (57202373490)
    ;
    Rauch, S. (55227483400)
    ;
    Dalfonso, S. (55765749900)
    ;
    Alvarez-Cermeño, J.C. (7004605927)
    ;
    Kleinová, P. (56534292400)
    ;
    Horáková, D. (55053678000)
    ;
    Roesler, R. (56637970800)
    ;
    Lauda, F. (36548278800)
    ;
    Llufriu, S. (57222877760)
    ;
    Avsar, T. (55318846300)
    ;
    Uygunoglu, U. (36708802800)
    ;
    Altintas, A. (7006317905)
    ;
    Saip, S. (55372483000)
    ;
    Menge, T. (6505932679)
    ;
    Rajda, C. (6603645376)
    ;
    Bergamaschi, R. (55335579500)
    ;
    Moll, N. (57193449971)
    ;
    Khalil, M. (55628524072)
    ;
    Marignier, R. (24462285700)
    ;
    Dujmovic, I. (6701590899)
    ;
    Larsson, H. (7101723846)
    ;
    Malmestrom, C. (7801366222)
    ;
    Scarpini, E. (57210771033)
    ;
    Fenoglio, C. (8661375900)
    ;
    Wergeland, S. (6505622090)
    ;
    Laroni, A. (14013173700)
    ;
    Annibali, V. (16024160900)
    ;
    Romano, S. (12753606700)
    ;
    Martínez, A.D. (58825527900)
    ;
    Carra, A. (6701687894)
    ;
    Salvetti, M. (55260565100)
    ;
    Uccelli, A. (7004263413)
    ;
    Torkildsen, Ø. (8714244300)
    ;
    Myhr, K.M. (7005382096)
    ;
    Galimberti, D. (6701617660)
    ;
    Rejdak, K. (8284992700)
    ;
    Lycke, J. (57205654889)
    ;
    Frederiksen, J.L. (7102315536)
    ;
    Drulovic, J. (55886929900)
    ;
    Confavreux, C. (7005816298)
    ;
    Brassat, D. (55666405000)
    ;
    Enzinger, C. (6602781849)
    ;
    Fuchs, S. (7202421454)
    ;
    Bosca, I. (15053035900)
    ;
    Pelletier, J. (57203082511)
    ;
    Picard, C. (59574720400)
    ;
    Colombo, E. (57196826545)
    ;
    Franciotta, D. (7003954703)
    ;
    Derfuss, T. (6602736963)
    ;
    Lindberg, R.L.P. (59876300900)
    ;
    Yaldizli, Ö. (24460802000)
    ;
    Vécsei, L. (35452449900)
    ;
    Kieseier, B.C. (7003500274)
    ;
    Hartung, H.P. (35372254600)
    ;
    Villoslada, P. (6602074839)
    ;
    Siva, A. (7004131839)
    ;
    Saiz, A. (56213393300)
    ;
    Tumani, H. (7003596212)
    ;
    Havrdová, E. (57201596736)
    ;
    Villar, L.M. (35518965300)
    ;
    Leone, M. (8696031300)
    ;
    Barizzone, N. (57190387724)
    ;
    Deisenhammer, F. (7004758773)
    ;
    Teunissen, C. (6701704380)
    ;
    Montalban, X. (7007177960)
    ;
    Tintoré, M. (35416724300)
    ;
    Olsson, T. (55550356500)
    ;
    Trojano, M. (7005165969)
    ;
    Lehmann, S. (7102616467)
    ;
    Castelnovo, G. (6601913935)
    ;
    Lapin, S. (7006205727)
    ;
    Hintzen, R. (26643157200)
    ;
    Kappos, L. (7004559324)
    ;
    Furlan, R. (7005770529)
    ;
    Martinelli, V. (7005415704)
    ;
    Comi, G. (7201788288)
    ;
    Ramagopalan, S.V. (14049256200)
    ;
    Giovannoni, G. (34770127900)
    Background and objective: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. Methods: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. Results: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. Conclusions: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study
    (2015)
    Kuhle, J. (8937520800)
    ;
    Disanto, G. (26631703200)
    ;
    Dobson, R. (36093903900)
    ;
    Adiutori, R. (56156549300)
    ;
    Bianchi, L. (57191438781)
    ;
    Topping, J. (12445497400)
    ;
    Bestwick, J.P. (14027999700)
    ;
    Meier, U.-C. (20734943500)
    ;
    Marta, M. (8578393000)
    ;
    Dalla Costa, G. (6506426520)
    ;
    Runia, T. (55315357700)
    ;
    Evdoshenko, E. (51763507000)
    ;
    Lazareva, N. (56720982800)
    ;
    Thouvenot, E. (35325407800)
    ;
    Iaffaldano, P. (25226936800)
    ;
    Direnzo, V. (25226632600)
    ;
    Khademi, M. (59554754700)
    ;
    Piehl, F. (7004836264)
    ;
    Comabella, M. (6701491362)
    ;
    Sombekke, M. (26024481200)
    ;
    Killestein, J. (7004423164)
    ;
    Hegen, H. (57202373490)
    ;
    Rauch, S. (55227483400)
    ;
    Dalfonso, S. (55765749900)
    ;
    Alvarez-Cermeño, J.C. (7004605927)
    ;
    Kleinová, P. (56534292400)
    ;
    Horáková, D. (55053678000)
    ;
    Roesler, R. (56637970800)
    ;
    Lauda, F. (36548278800)
    ;
    Llufriu, S. (57222877760)
    ;
    Avsar, T. (55318846300)
    ;
    Uygunoglu, U. (36708802800)
    ;
    Altintas, A. (7006317905)
    ;
    Saip, S. (55372483000)
    ;
    Menge, T. (6505932679)
    ;
    Rajda, C. (6603645376)
    ;
    Bergamaschi, R. (55335579500)
    ;
    Moll, N. (57193449971)
    ;
    Khalil, M. (55628524072)
    ;
    Marignier, R. (24462285700)
    ;
    Dujmovic, I. (6701590899)
    ;
    Larsson, H. (7101723846)
    ;
    Malmestrom, C. (7801366222)
    ;
    Scarpini, E. (57210771033)
    ;
    Fenoglio, C. (8661375900)
    ;
    Wergeland, S. (6505622090)
    ;
    Laroni, A. (14013173700)
    ;
    Annibali, V. (16024160900)
    ;
    Romano, S. (12753606700)
    ;
    Martínez, A.D. (58825527900)
    ;
    Carra, A. (6701687894)
    ;
    Salvetti, M. (55260565100)
    ;
    Uccelli, A. (7004263413)
    ;
    Torkildsen, Ø. (8714244300)
    ;
    Myhr, K.M. (7005382096)
    ;
    Galimberti, D. (6701617660)
    ;
    Rejdak, K. (8284992700)
    ;
    Lycke, J. (57205654889)
    ;
    Frederiksen, J.L. (7102315536)
    ;
    Drulovic, J. (55886929900)
    ;
    Confavreux, C. (7005816298)
    ;
    Brassat, D. (55666405000)
    ;
    Enzinger, C. (6602781849)
    ;
    Fuchs, S. (7202421454)
    ;
    Bosca, I. (15053035900)
    ;
    Pelletier, J. (57203082511)
    ;
    Picard, C. (59574720400)
    ;
    Colombo, E. (57196826545)
    ;
    Franciotta, D. (7003954703)
    ;
    Derfuss, T. (6602736963)
    ;
    Lindberg, R.L.P. (59876300900)
    ;
    Yaldizli, Ö. (24460802000)
    ;
    Vécsei, L. (35452449900)
    ;
    Kieseier, B.C. (7003500274)
    ;
    Hartung, H.P. (35372254600)
    ;
    Villoslada, P. (6602074839)
    ;
    Siva, A. (7004131839)
    ;
    Saiz, A. (56213393300)
    ;
    Tumani, H. (7003596212)
    ;
    Havrdová, E. (57201596736)
    ;
    Villar, L.M. (35518965300)
    ;
    Leone, M. (8696031300)
    ;
    Barizzone, N. (57190387724)
    ;
    Deisenhammer, F. (7004758773)
    ;
    Teunissen, C. (6701704380)
    ;
    Montalban, X. (7007177960)
    ;
    Tintoré, M. (35416724300)
    ;
    Olsson, T. (55550356500)
    ;
    Trojano, M. (7005165969)
    ;
    Lehmann, S. (7102616467)
    ;
    Castelnovo, G. (6601913935)
    ;
    Lapin, S. (7006205727)
    ;
    Hintzen, R. (26643157200)
    ;
    Kappos, L. (7004559324)
    ;
    Furlan, R. (7005770529)
    ;
    Martinelli, V. (7005415704)
    ;
    Comi, G. (7201788288)
    ;
    Ramagopalan, S.V. (14049256200)
    ;
    Giovannoni, G. (34770127900)
    Background and objective: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. Methods: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. Results: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. Conclusions: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
    (2020)
    Leurs, C.E. (56866079400)
    ;
    Twaalfhoven, H.A.M. (26533533200)
    ;
    Lissenberg-Witte, B.I. (57204744042)
    ;
    van Pesch, V. (15847200900)
    ;
    Dujmovic, I. (6701590899)
    ;
    Drulovic, J. (55886929900)
    ;
    Castellazzi, M. (57190160648)
    ;
    Bellini, T. (7004337741)
    ;
    Pugliatti, M. (6603827112)
    ;
    Kuhle, J. (8937520800)
    ;
    Villar, L.M. (35518965300)
    ;
    Alvarez-Cermeño, J.C. (7004605927)
    ;
    Alvarez-Lafuente, R. (13411081600)
    ;
    Hegen, H. (57202373490)
    ;
    Deisenhammer, F. (7004758773)
    ;
    Walchhofer, L.M. (57194580116)
    ;
    Thouvenot, E. (35325407800)
    ;
    Comabella, M. (6701491362)
    ;
    Montalban, X. (7007177960)
    ;
    Vécsei, L. (35452449900)
    ;
    Rajda, C. (6603645376)
    ;
    Galimberti, D. (6701617660)
    ;
    Scarpini, E. (57210771033)
    ;
    Altintas, A. (7006317905)
    ;
    Rejdak, K. (8284992700)
    ;
    Frederiksen, J.L. (7102315536)
    ;
    Pihl-Jensen, G. (56568478300)
    ;
    Jensen, P.E.H. (57214664093)
    ;
    Khalil, M. (55628524072)
    ;
    Voortman, M.M. (57195917900)
    ;
    Fazekas, F. (7102945505)
    ;
    Saiz, A. (56213393300)
    ;
    La Puma, D. (56422282100)
    ;
    Vercammen, M. (6602461163)
    ;
    Vanopdenbosch, L. (6602558181)
    ;
    Uitdehaag, B.M.J. (57243388200)
    ;
    Killestein, J. (7004423164)
    ;
    Bridel, C. (6508071655)
    ;
    Teunissen, C. (6701704380)
    Objective: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). Methods: We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients) with a known oligoclonal IgG band (OCB) status. KFLC and LFLC were measured in paired cerebrospinal fluid (CSF) and serum samples. Gaussian mixture modeling was used to define a cut-off for KFLC and LFLC indexes. Results: The cut-off for the KFLC index was 6.6 (95% confidence interval (CI) = 5.2–138.1). The cut-off for the LFLC index was 6.9 (95% CI = 4.5–22.2). For CIS/MS patients, sensitivity of the KFLC index (0.88; 95% CI = 0.85–0.90) was higher than OCB (0.82; 95%CI = 0.79–0.85; p < 0.001), but specificity (0.83; 95% CI = 0.78–0.88) was lower (OCB = 0.92; 95% CI = 0.89–0.96; p < 0.001). Both sensitivity and specificity for the LFLC index were lower than OCB. Conclusion: Compared with OCB, the KFLC index is more sensitive but less specific for diagnosing CIS/MS. Lacking an elevated KFLC index is more powerful for excluding MS compared with OCB but the latter is more important for ruling in a diagnosis of CIS/MS. © The Author(s), 2019.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
    (2020)
    Leurs, C.E. (56866079400)
    ;
    Twaalfhoven, H.A.M. (26533533200)
    ;
    Lissenberg-Witte, B.I. (57204744042)
    ;
    van Pesch, V. (15847200900)
    ;
    Dujmovic, I. (6701590899)
    ;
    Drulovic, J. (55886929900)
    ;
    Castellazzi, M. (57190160648)
    ;
    Bellini, T. (7004337741)
    ;
    Pugliatti, M. (6603827112)
    ;
    Kuhle, J. (8937520800)
    ;
    Villar, L.M. (35518965300)
    ;
    Alvarez-Cermeño, J.C. (7004605927)
    ;
    Alvarez-Lafuente, R. (13411081600)
    ;
    Hegen, H. (57202373490)
    ;
    Deisenhammer, F. (7004758773)
    ;
    Walchhofer, L.M. (57194580116)
    ;
    Thouvenot, E. (35325407800)
    ;
    Comabella, M. (6701491362)
    ;
    Montalban, X. (7007177960)
    ;
    Vécsei, L. (35452449900)
    ;
    Rajda, C. (6603645376)
    ;
    Galimberti, D. (6701617660)
    ;
    Scarpini, E. (57210771033)
    ;
    Altintas, A. (7006317905)
    ;
    Rejdak, K. (8284992700)
    ;
    Frederiksen, J.L. (7102315536)
    ;
    Pihl-Jensen, G. (56568478300)
    ;
    Jensen, P.E.H. (57214664093)
    ;
    Khalil, M. (55628524072)
    ;
    Voortman, M.M. (57195917900)
    ;
    Fazekas, F. (7102945505)
    ;
    Saiz, A. (56213393300)
    ;
    La Puma, D. (56422282100)
    ;
    Vercammen, M. (6602461163)
    ;
    Vanopdenbosch, L. (6602558181)
    ;
    Uitdehaag, B.M.J. (57243388200)
    ;
    Killestein, J. (7004423164)
    ;
    Bridel, C. (6508071655)
    ;
    Teunissen, C. (6701704380)
    Objective: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). Methods: We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients) with a known oligoclonal IgG band (OCB) status. KFLC and LFLC were measured in paired cerebrospinal fluid (CSF) and serum samples. Gaussian mixture modeling was used to define a cut-off for KFLC and LFLC indexes. Results: The cut-off for the KFLC index was 6.6 (95% confidence interval (CI) = 5.2–138.1). The cut-off for the LFLC index was 6.9 (95% CI = 4.5–22.2). For CIS/MS patients, sensitivity of the KFLC index (0.88; 95% CI = 0.85–0.90) was higher than OCB (0.82; 95%CI = 0.79–0.85; p < 0.001), but specificity (0.83; 95% CI = 0.78–0.88) was lower (OCB = 0.92; 95% CI = 0.89–0.96; p < 0.001). Both sensitivity and specificity for the LFLC index were lower than OCB. Conclusion: Compared with OCB, the KFLC index is more sensitive but less specific for diagnosing CIS/MS. Lacking an elevated KFLC index is more powerful for excluding MS compared with OCB but the latter is more important for ruling in a diagnosis of CIS/MS. © The Author(s), 2019.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2
    (2017)
    Rakocevic-Stojanovic, V. (6603893359)
    ;
    Peric, S. (35750481700)
    ;
    Dujmovic, I. (6701590899)
    ;
    Drulovic, J. (55886929900)
    ;
    Pesovic, J. (15725996300)
    ;
    Savic-Pavicevic, D. (18435454500)
    The aim of this study was to present a family co-segregating myotonic dystrophy type 1 (DM1) and 2 (DM2), and one member affected with neuromyelitis optica (NMO). Case report: Index case underwent cataract surgery at age 39. Although she had no muscle symptoms, genetic testing revealed a DM2 mutation and a DM1 protomutation. The patient noticed difficulties in climbing stairs at age 47. Clinical examination showed mild muscle weakness, calf hypertrophy, mild myotonia and several multisystem signs. Patient's mother had DM1 protomutation and clinically exhibited only cataract. Two proband's sisters, one with DM2 mutation and another with DM2 mutation and DM1 protomutation, had a clinical presentation similar to the index case. In addition, the latter also developed NMO. Conclusion: Our findings suggest that screening for both DM1 and DM2 should be done and a positive result in either gene should not be an indication to stop screening, but to move to the other gene. © 2017 - IOS Press and the authors. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2
    (2017)
    Rakocevic-Stojanovic, V. (6603893359)
    ;
    Peric, S. (35750481700)
    ;
    Dujmovic, I. (6701590899)
    ;
    Drulovic, J. (55886929900)
    ;
    Pesovic, J. (15725996300)
    ;
    Savic-Pavicevic, D. (18435454500)
    The aim of this study was to present a family co-segregating myotonic dystrophy type 1 (DM1) and 2 (DM2), and one member affected with neuromyelitis optica (NMO). Case report: Index case underwent cataract surgery at age 39. Although she had no muscle symptoms, genetic testing revealed a DM2 mutation and a DM1 protomutation. The patient noticed difficulties in climbing stairs at age 47. Clinical examination showed mild muscle weakness, calf hypertrophy, mild myotonia and several multisystem signs. Patient's mother had DM1 protomutation and clinically exhibited only cataract. Two proband's sisters, one with DM2 mutation and another with DM2 mutation and DM1 protomutation, had a clinical presentation similar to the index case. In addition, the latter also developed NMO. Conclusion: Our findings suggest that screening for both DM1 and DM2 should be done and a positive result in either gene should not be an indication to stop screening, but to move to the other gene. © 2017 - IOS Press and the authors. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients
    (2002)
    Miljkovic, Dj. (7006524033)
    ;
    Drulovic, J. (55886929900)
    ;
    Trajkovic, V. (7004516866)
    ;
    Mesaros, S. (7004307592)
    ;
    Dujmovic, I. (6701590899)
    ;
    Maksimovic, D. (6507584634)
    ;
    Samardzic, T. (6602855000)
    ;
    Stojsavljevic, N. (6603086728)
    ;
    Levic, Z. (7003341242)
    ;
    Mostarica Stojkovic, M. (6701741422)
    Interleukin-6 (IL-6) and nitric oxide (NO) are implicated in the pathology of multiple sclerosis (MS). We have investigated the levels of these mediators in the cerebrospinal fluid (CSF) from 50 patients with MS and 23 control subjects. Mean CSF IL-6 level was higher in the total MS group in comparison with controls, but not significantly, whilst the difference between patients with stable MS and controls reached the level of statistical significance. Mean CSF nitrite/nitrate level was significantly higher in the total MS group compared with the control group, as well as in active MS patients versus controls. There was significant difference neither in the mean CSF IL-6 nor in nitrite/nitrate levels between active and stable MS patients. Interestingly, we observed a significant negative correlation between IL-6 and nitrite/nitrate levels in the CSF in the total MS group. Such a trend existed in both subgroups with active and stable MS, but without reaching the level of statistical significance. Our data further support the involvement of IL-6 and NO in ongoing pathological processes in MS, suggesting their potential interplay within the central nervous system in this disease.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients
    (2002)
    Miljkovic, Dj. (7006524033)
    ;
    Drulovic, J. (55886929900)
    ;
    Trajkovic, V. (7004516866)
    ;
    Mesaros, S. (7004307592)
    ;
    Dujmovic, I. (6701590899)
    ;
    Maksimovic, D. (6507584634)
    ;
    Samardzic, T. (6602855000)
    ;
    Stojsavljevic, N. (6603086728)
    ;
    Levic, Z. (7003341242)
    ;
    Mostarica Stojkovic, M. (6701741422)
    Interleukin-6 (IL-6) and nitric oxide (NO) are implicated in the pathology of multiple sclerosis (MS). We have investigated the levels of these mediators in the cerebrospinal fluid (CSF) from 50 patients with MS and 23 control subjects. Mean CSF IL-6 level was higher in the total MS group in comparison with controls, but not significantly, whilst the difference between patients with stable MS and controls reached the level of statistical significance. Mean CSF nitrite/nitrate level was significantly higher in the total MS group compared with the control group, as well as in active MS patients versus controls. There was significant difference neither in the mean CSF IL-6 nor in nitrite/nitrate levels between active and stable MS patients. Interestingly, we observed a significant negative correlation between IL-6 and nitrite/nitrate levels in the CSF in the total MS group. Such a trend existed in both subgroups with active and stable MS, but without reaching the level of statistical significance. Our data further support the involvement of IL-6 and NO in ongoing pathological processes in MS, suggesting their potential interplay within the central nervous system in this disease.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Quality of life in patients with multiple sclerosis in Serbia
    (2007)
    Drulovic, J. (55886929900)
    ;
    Pekmezovic, T. (7003989932)
    ;
    Matejic, B. (9840705300)
    ;
    Mesaros, S. (7004307592)
    ;
    Manigoda, M. (15842202300)
    ;
    Dujmovic, I. (6701590899)
    ;
    Stojsavljevic, N. (6603086728)
    ;
    Kocev, N. (6602672952)
    ;
    Gavric-Kezic, M. (15841566100)
    ;
    Nikic, P. (26433763500)
    ;
    Dragojlovic, M. (15841478000)
    Objectives - The aim of this investigation was to evaluate factors that might influence the health-related quality of life (HRQoL) in multiple sclerosis (MS) patients in Serbia. Materials and methods - This cross-sectional study was performed on a group of 156 patients with MS. HRQoL was assessed by using the SF-36 questionnaire. Expanded Disability Status Scale (EDSS) and Beck Depression Inventory (BDI) scale were assessed as variables affecting the HRQoL of MS patients. Results - EDSS score correlated negatively with all SF-36 health dimensions, and the highest statistically significant coefficients were for physical functioning (r = -0.682), and social and role functioning (r = -0.407 and -0.405 respectively). BDI correlated statistically significantly negatively (P < 0.01) with all SF-36 health dimensions. Conclusions - Our findings suggest that both disability and depression significantly influence the HRQoL in Serbian MS patients, with depressive symptoms having the major influence. © 2007 The Authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Quality of life in patients with multiple sclerosis in Serbia
    (2007)
    Drulovic, J. (55886929900)
    ;
    Pekmezovic, T. (7003989932)
    ;
    Matejic, B. (9840705300)
    ;
    Mesaros, S. (7004307592)
    ;
    Manigoda, M. (15842202300)
    ;
    Dujmovic, I. (6701590899)
    ;
    Stojsavljevic, N. (6603086728)
    ;
    Kocev, N. (6602672952)
    ;
    Gavric-Kezic, M. (15841566100)
    ;
    Nikic, P. (26433763500)
    ;
    Dragojlovic, M. (15841478000)
    Objectives - The aim of this investigation was to evaluate factors that might influence the health-related quality of life (HRQoL) in multiple sclerosis (MS) patients in Serbia. Materials and methods - This cross-sectional study was performed on a group of 156 patients with MS. HRQoL was assessed by using the SF-36 questionnaire. Expanded Disability Status Scale (EDSS) and Beck Depression Inventory (BDI) scale were assessed as variables affecting the HRQoL of MS patients. Results - EDSS score correlated negatively with all SF-36 health dimensions, and the highest statistically significant coefficients were for physical functioning (r = -0.682), and social and role functioning (r = -0.407 and -0.405 respectively). BDI correlated statistically significantly negatively (P < 0.01) with all SF-36 health dimensions. Conclusions - Our findings suggest that both disability and depression significantly influence the HRQoL in Serbian MS patients, with depressive symptoms having the major influence. © 2007 The Authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Transverse myelopathy in the antiphospholipid antibody syndrome: Pinworm infestation as a trigger?
    (2000)
    Drulovic, J. (55886929900)
    ;
    Dujmovic, I. (6701590899)
    ;
    Stojsavljevic, N. (6603086728)
    ;
    Tripkovic, I. (55287302100)
    ;
    Apostolski, S. (7004532054)
    ;
    Levic, Z. (7003341242)
    ;
    Stojkovic, M.M. (6701741422)
    ;
    Bonaci, B. (6506842867)
    ;
    Andrejevic, S. (6701472920)
    [No abstract available]

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback